WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 2'7601 Infant (under 12 months) mortality rate: 782
GDP / capita (US$): 5'8631 Child (under 5 years) mortality rate: 1242

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 178'517  173'615  168'834  164'193  159'708  122'877  95'617  73'698 
Births 7'310  7'173  7'028  6'876  6'718  5'281  4'220  3'441 
Surviving infants 6'779  6'635  6'483  6'325  6'161  4'691  3'686  2'998 
Pop. less than 5 years 31'370  30'546  29'697  28'849  28'006  21'084  16'809  13'373 
Pop. less than 15 years 79'259  77'009  74'742  72'500  70'307  53'456  42'909  32'411 
Female 15-49 years 40'237  39'171  38'161  37'198  36'277  28'084  21'183  16'567 

Number of reported case

(Click for retrospective incidence data for Nigeria)
Diphtheria 3'995  1'768  165 
Japanese encephalitis
Measles 6'855  52'852  6'447  18'843  8'491  212'183  115'682  162'106 
Mumps
Pertussis 9'559  8'530  11'628  38'910  42'929  48'996 
Polio* 57  130  95  48  638  1'873  816 
Rubella 102  88  239  3'691  450 
Rubella (CRS)
Tetanus (neonatal) 104  468  110  82  176  1'643  1'060 
Tetanus (total)** 208  556  112  114  199  1'643  2'703  3'095 
Yellow fever 387  4'075 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nigeria)
Vaccine year result method % card seen                                                
BCG 2012  51  DHS   28  73  69  87  60  66  34  80 
DTP1 2012  51  DHS   28  76  72  67  68  84  48 
DTP3 2012  38  DHS   28  70  65  57  61  74  38  56 
HepB_BD          54  12  12 
HepB3 2010  36  MICS   24  70  65  84  57  66 
Hib3          70  55  62 
JapEnc         
MCV          73  73  78  93  85  30  48 
MCV2         
PCV1         
PCV3         
Pol3 2012  54  DHS   28  72  67  77  74  69  38  55 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  51  MICS   24  44  39  56  44  39  56 
PAB         
VAD1          12 
YFV 2010  50  MICS   24  71  64  46  72  78 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nigeria)
BCG 80  73  46  62  44  80 
DTP1 63  32  33  60  42  79 
DTP3 58  26  30  54  29  56 
HepB3 63  47  31  49 
HepB_BD 37  32  31  29 
Hib3 46  10 
MCV 59  37  52  56  33  54 
MCV2
PAB 60  60  60  69  57  32 
PCV3
Pol3 67  52  49  54  31  55 
Rota_last
YFV 49  33  50 

Number of districts in the country 774  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
94 
   
/
|
|
\
Greater or equal to 90% 61
From 80 to 89% 19
From 50 to 79% 17
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 6, 10, 14 weeks; No
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV Yes From January 2018
HepB birth; 6, 14 weeks; Yes
IPV Yes From February 2015
Measles 9 months; Yes
MenA 9 months; Yes From January 2016
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj Yes From January 2015
Rotavirus Yes From January 2017
TT 1st contact in pregnancy; +1, +6 months; +1, +1 years; Yes
Td 1st contact in pregnancy; +1, +6 months; +1, +1 years; Yes From January 2016
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011- 2015  2011- 2015  2009 - 2014  2009-2014  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 705  774  774  774      425 

System performance

Total Nº districts in country number 774  774  774  774  774  774  774 
Nº districts with DTP3 coverage >=80% number 616  554  117  125  309  406  244 
% of districts with DTP3 coverage >=80% From 0 to 100% 80  72  15  16  40  52  32 
Nº districts with measles (MCV1) coverage >=95% number 409  393  192  255  251  304  263 
% of districts with MCV1 coverage >=95% From 0 to 100% 53  51  25  33  32  39  34 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes    No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes    No  No  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 24        89    70 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.